EAST WINDSOR, NJ -- (MARKET WIRE) -- January 29, 2007 -- NexMed, Inc. (NASDAQ: NEXM), a developer of innovative topical treatments based on its NexACT® drug delivery technology, today announced, effective immediately, the appointment of David S. Tierney, M.D. to the Company's Board of Directors. Dr. Tierney will serve on NexMed's Board until the 2008 Annual Meeting of Stockholders, and brings the Board to six members.
